Alzamend Neuro issues 361,743 shares on Series B Preferred conversion

Alzamend Neuro, Inc.

Between Oct 1-8, 2025, 361,743 shares issued upon conversion of ~839.2 Series B Convertible Preferred shares.
Shares issued under Section 4(a)(2) exemption from registration.
As of Oct 8, 2025, total common shares outstanding: 3,801,604.
Conversion increases outstanding share count by roughly 10.5% from prior level.

item 3.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Alzamend Neuro, Inc. issued 361,743 shares of common stock.

Security: common stock
Shares: 361,743 shares

Exact text from the filing

Between October 1, 2025 and October 8, 2025, Alzamend Neuro, Inc. (the “ Company ”) issued an aggregate of 361,743 shares of common stock, par value $0.0001 per share (“ Common Stock ”) upon conversion of an aggregate of approximately 839.2 shares of Series B Convertible Preferred Stock.

View on SEC.gov

Browse all equity issuances →

Alzamend Neuro, Inc. filing history →

Source: SEC EDGAR

accession 0001214659-25-014818

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.